D-0001-2021 Class II Terminated

Recalled by Strides Inc. — Lambertville, NJ

Recall Details

Product Type
Drugs
Report Date
October 7, 2020
Initiation Date
August 24, 2020
Termination Date
January 11, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,280 bottles

Product Description

Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

nationwide

Code Information

7240675A; Exp. 12/31/2021